Page 1 of 515
`
`NOVATEL EXHIBIT 1011
`
`

`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.goV
`
`APPLICATION NO.
`
`F ING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONF {MATION NO.
`
`13/328,095
`
`12/16/2011
`
`Eveline Wesby—Van Swaay
`
`3781/1007
`
`5730
`
`Sunstein Kann Murphy & Timbers LLP
`”’23’””
`759°
`2””
`125 S UMMER S TREET
`NGUYEN, NAM V
`BOSTON, MA 02110-1618
`
`PAPER NUMBER
`
`ART UNIT
`
`26 82
`
`NOT *ICATION DATE
`
`DELIVERY MODE
`
`12/23/2013
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on aboVe—indicated "Notification Date" to the
`following e—mail address(es):
`
`usptomail@sunsteinlaW.c0m
`
`PTOL—90A (Rev. 04/07)
`Page 2 of 515
`
`Page 2 of 515
`
`

`
`Supplemental
`Notice of Allowability
`
`Application No.
`13/328,095
`fig/|m\i/rj<fqrGUYEN
`
`App|icant(s)
`WESBY—VAN SWAAY, EVELINE
`Qgtggnit
`;‘,'{;,<§‘,;it,',""°"*°'*°
`No
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application.
`If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL—85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. IXI This communication is responsive to 12/2/2013.
`
`I: A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on
`
`2. I:I An election was made by the applicant in response to a restriction requirement set forth during the interview on
`requirement and election have been incorporated into this action.
`
`; the restriction
`
`3. E The allowed cIaim(s) is/are 21-51. As a result of the allowed cIaim(s), you may be eligible to benefit from the Patent Prosecution
`Highway program at a participating intellectual property office for the corresponding application. For more information, please see
`hit’ :/'.:’vwvvv.L.=s ‘to. ov/ atents/init events/'
`h/'incie;»<.‘s orsend an inquiry to PPHfeedback@us;;I:o.qov.
`
`4. I:I Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)—(d) or (f).
`
`Certified copies:
`
`a) [I All
`
`b) I] Some
`
`*c) I:I None of the:
`
`1. D Certified copies of the priority documents have been received.
`
`2. D Certified copies of the priority documents have been received in Application No. j
`
`3. El Copies of the certified copies of the priority documents have been received in this national stage application from the
`
`International Bureau (PCT Rule 17.2(a)).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE” of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5. I:I CORRECTED DRAWINGS (as “replacement sheets”) must be submitted.
`
`I:I
`
`including changes required by the attached Examiner’s Amendment / Comment or in the Office action of
`Paper No./Mail Date
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawings in the front (not the back) of
`each sheet. Replacement sheet(s) should be labeled as such in the header according to 37 CFR 1.121(d).
`
`6. El DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner’s comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. El Notice of References Cited (PTO—892)
`
`2. IX Information Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date 12/2/13
`3. El Examiner’s Comment Regarding Requirement for Deposit
`of Biological Material
`4. I:I Interview Summary (PTO—413),
`Paper No./Mail Date
`
`/NAM V NGUYEN/
`
`Primary Examiner, Art Unit 2682
`
`5. El Examiner’s Amendment/Comment
`
`6. El Examiner’s Statement of Reasons for Allowance
`
`7. El Other
`
`.
`
`U.S. Patent and Trademark Office
`
`PTOL-37 (Rev. 08-13)
`
`Page 3 of 515
`
`Notice of Allowability
`
`Part of Paper No./Mail Date 20131216
`
`Page 3 of 515
`
`

`
`PTO!SBf08a (01-10)
`Doc code: IDS
`th
`df
`A
`h 07/302012. OMB 0651-0031
`.
`.
`.
`.
`.
`U_s_ Patent and Tragzggfk O‘:;::eU_§"EfiEPARTMENT OF COMMERCE
`Doc description: Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Application Number
`
`Filing Date
`
`13328095
`
`2011-12-16
`
`First Named Inventor
`Eveline Wesby—van Swaay
`Art Unit
`| 2682
`Examiner Name
`Nam V. Nguyen
`Attorney Docket Number
`| 3781/1007
`
`E).(‘?m*iner Cite
`
`Initial
`
`No
`
`U.S.PATENTS
`
`Rem°Ve
`
`Patent Number
`
`Kind
`
`Code1
`
`Issue Date
`
`Na“.“° of Patentee or Applicant
`
`of cited Document
`
`::IJee\1:I'i:toPuar:::g|:=.i:e<:' VR:I:r:ant
`
`.
`Figures Appear
`
`1
`
`If you wish to add additional U.S. Patent citation information please click the Add button.
`
`U.S.PATENT APPLICATION PUBLICATIONS
`
`Add
`
`Rem°Ve
`
`Examiner
`.
`.
`,,
`Initial
`
`.
`Cite No
`
`Publication
`Number
`
`Publication
`Kind
`Codet Date
`
`Name of Patentee or Applicant PageS’C°|umn5'Line5 Where
`.
`Relevant Passages or Relevant
`of cited Document
`Figures Appear
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`
`FOREIGN PATENT DOCUMENTS
`
`R9m0Ve
`
`Examiner Cite Foreign Document
`|nitia|*
`No
`Number3
`
`Country
`Code2 i
`
`Publication
`Kind
`Code4 Date
`
`Name of Patentee or
`A “cant of cited
`Dpp
`ocument
`
`Pages,Co|umns,Lines
`where Relevant
`Passages or Relevant
`.
`Figures Appear
`
`1
`
`D
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`
`Add
`
`NON-PATENT LITERATURE DOCUMENTS
`
`R9m0Ve
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`.
`.
`.
`.
`.
`.
`.
`Examiner Cite
`T5
`(book, magazine, Journal, serial, symposium, catalog, etc}, date, pages(s), volume-issue number(s),
`.
`.
`publisher, city and/or country where published.
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED TRRDUGR.
`
`/N.i\£./
`
`Page 4 of 515
`
`Page 4 of 515
`
`

`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Application Number
`
`13328095
`
`2011-12-16
`Filing Date
`Eveline Wesby—van Swaay
`First Named Inventor
`lm
`A“ Unit
`Nam V Nguyen
`Examiner Name
`Attorney Docket Number
`| 3781/1007
`
`M2M Solutions LLC v. Sierra Wireless American, Inc. and Sierra Wireless, Inc. et al., U.S.D.C. for the District of
`
`Delaware — Civil Action No. 12—030—RGA, Memorandum Opinion, served on November 12, 2013 (20 pages) {REF_HL}
`
`If you wish to add additional non-patent literature document citation information please click the Add button Add
`EXAMINER SIGNATURE
`
`Examiner Signature
`
`
`/Nam Nguyenl
`Date Considered
`
`I2/1 5/2013
`
`*EXAM|NER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`2 Enter office that issued the document, by the two-letter code (WIPO
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04.
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible.
`5 Applicant is to place a check mark here if
`English language translation is attached.
`
`EFSWeb2.1.17
`
`ALL REFERENCES COE\lS§{i)EREl3 EXCEPT WHERE LINED THRQUGH.
`
`/l\I.I\£./
`
`Page 5 of 515
`
`Page 5 of 515
`
`

`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Application Number
`
`13328095
`
`Filing Date
`
`2011-12-16
`
`First Named Inventor
`Eveline Wesby-van Swaay
`Art Unit
`| 2682
`Examiner Name
`Nam V. Nguyen
`Attorney Docket Number
`| 3781/1007
`
`CERTIFICATION STATEMENT
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate se|ection(s):
`
`|:I
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`|:| See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`|:| A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`Signature
`
`NamelPrint
`
`/Jonathan C. Lovely, #60,821/
`
`Date (YYYY-MM-DD)
`
`2013-12-02
`
`60821
`
`Jonathan C. Lovely
`
`Registration Number
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFSWeb2.1.17
`
`ALL REFERENCES COE\lS§{i)EREl3 EXCEPT WHERE LlNE{) THROUGH.
`
`/l\l.l\£./
`
`Page 6 of 515
`
`Page 6 of 515
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record s.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`9.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`ALL REFERENCES COE\lSl{I}EREl3 EXCEPT WHERE LlNE{) TFERQUGH.
`P%"§é“I"c>f 515
`
`/l\i.¥\E./’
`
`Page 7 of 515
`
`

`
`U.S. DEPARTMENT OF COMMERCE
`PATENT AND TRADEMARK OFFICE
`
`PATENT WITHDRAWAL NOTICE
`
`DATE WITHDRAWN
`
`WITHDRAWAL NUMBER
`
`The following application has been WITHDRAWN from the
`
`12/17/2013 issue.
`
`SERIAL NO.
`
`,
`
`PATENT NUMBER
`
`13328095
`
`8610540
`
`NAME AND ADDRESS
`
`EVELINE WESBY-VAN SWAAY
`TIDDINGTON, GERMANY
`
`REASON FOR WITHDRAWAL
`
`Auto-petition to withdraw - Granted.
`
`APPROVED
`
`FORM PTO—302 -- (REV. 05-2009)
`
`Page 8 of 515
`
`/Kimberly Terrell/, Manager
`
`Patent Publication Branch
`
`Office of Data Management
`
`Page 8 of 515
`
`

`
`PTOISBIEBOEFS (07-09)
`Doc code: RCEX
`Approved for use through 0'-’r'31f2012. OMB 0551-0031
`Doc description: Request for Continued Examination (RCE)
`u.s. Patent and Trademark Office; u.s. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`REQUEST FOR CONTINUED EXAMINATION(RCE)TRANSMlTTAL
`(Submitted Only via EFS-Web)
`
`A'°p”°ati°”
`Number
`First Named
`Inventor
`
`13/328095
`'
`
`.
`Eveline Wesby—van Swaay
`
`2011-12-16
`
`D°°ketN”mb°'
`(if applicable)
`Examiner
`Name
`
`3781/1007
`
`Nguyen, Nam V.
`
`This is a Request for Continued Examination (RCE) under 37 CFR 1.1 14 of the above-identified application.
`Request for Continued Examination (RCE) practice under 37 CFR 1.114 does not apply to any utility or plant application filed prior to June 8,
`1995, or to any design application. The Instruction Sheet for this form is located at WWW.USPTO.GOV
`
`SUBMISSION REQUIRED UNDER 37 CFR1.114
`
`Note: If the RCE is proper, any previously filed unentered amendments and amendments enclosed with the RCE will be entered in the order
`in which they were filed unless applicant instructs othenn/ise. If applicant does not wish to have any previously filed unentered amendment(s)
`entered, applicant must request non—entry of such amendment(s).
`
`|:| Previously submitted. If a final Office action is outstanding, any amendments filed after the final Office action may be considered as a
`submission even if this box is not checked.
`
`|:| Consider the arguments in the Appeal Brief or Reply Brief previously filed on
`
`|:| Other
`
`|Z| Enclosed
`
`|:| AmendmentlRep|y
`
`Information Disclosure Statement (IDS)
`
`|:| Affidavit(s)/ Dec|aration(s)
`
`Other
`
`Petition to Withdraw from Issue and Certification and Request for Consideration of an Information Disclosure
`Statement Filed after Payment of the Issue Fee under the QPIDS Pilot Program
`
`MISCELLANEOUS
`
`El Suspension of action on the above-identified application is requested under 37 CFR 1.103(c) for a period of months
`(Period of suspension shall not exceed 3 months; Fee under 37 CFR 1.17(i) required)
`
`|:| Other
`
`The RCE fee under 37 CFR 1.17(e) is required by 37 CFR 1.114 when the RCE is filed.
`The Director is hereby authorized to charge any underpayment of fees, or credit any overpayments, to
`Deposit Account No
`194972
`
`SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED
`
`FEES
`
`Patent Practitioner Signature
`
`|:| Applicant Signature
`
`P§gé"’9b6-I‘ -5515
`
`Page 9 of 515
`
`

`
`PTOISBIEBOEFS (07-09)
`Doc code: RCEX
`Approved for use through 0'-’r'31t2012. OMB 0551-0031
`Doc description: Request for Continued Examination (RCE)
`u.s_ Patent and Trademark Office; u_s. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Signature of Registered U.S. Patent Practitioner
`
` Name
`
`Jonathan C. Lovely
`
`Registration Number
`
`60821
`
`This collection of information is required by 37 CFR 1.114. The information is required to obtain or retain a benefit by the public which is to
`file (and by the USPTO to process) an application. Confidentiality is governed by 35 U_S_C_ 122 and 37 CFR 1.11 and 1.14. This collection is
`estimated to take 12 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time
`will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for
`reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce,
`P_O_ Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1—800—PTO—9199 and select option 2.
`
`eagewozo-rs15
`
`Page 10 of 515
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be
`advised that:
`(1) the general authority for the collection of this information is 35 U.S_C. 2(b)(2); (2) furnishing of the information
`solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office
`is to process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information
`Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need
`for the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization,
`pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services,
`or his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may
`be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in an
`application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS — Web 2.1.15
`
`Page 11 of 515
`
`Page 11 of 515
`
`

`
`Doc Code; PET_AUTO
`
`U.S. Patent and Trademark Office
`
`PTO/SB/ 1 40
`
`Document Description: Petition automatically granted by EFS—Web
`Department Of Commerce
`
`
`Electronic Petition Request
`
`PETITION TO WITHDRAW AN APPLICATION FROM ISSUE AFTER PAYMENT OF
`THE ISSUE FEE UNDER 37 CFR1.313(c)
`
`Application Number
`
`13323095
`
`Filing Date
`
`16—Dec—201 I
`
`First Named Inventor
`
`Eveline Wesby—van Swaay
`
`Art Unit
`
`2682
`
`Examiner Name
`
`NAM NGUYEN
`
`Attorney Docket Number
`
`3781/1007
`
`Title
`
`Programmable Communicator
`
`An application may be withdrawn from issue for further action upon petition by the applicant. To request that the Office
`withdraw an application from issue, applicant must file a petition under this section including the fee set forth in § 1.17(h) and a
`showing of good and sufficient reasons why withdrawal of the application from issue is necessary.
`
`APPLICANT HEREBY PETITIONS TO WITH DRAW THIS APPLICATION FROM ISSUE UNDER 37 CFR1.313(c).
`
`A grantable petition requires the following items:
`(1) Petition fee; and
`(2) One ofthe following reasons:
`(a) Unpatentability ofone or more claims, which must be accompanied by an unequivocal statement that one or more claims
`are unpatentable, an amendment to such claim or claims, and an explanation as to how the amendment causes such claim or
`claims to be patentable;
`(b) Consideration ofa request for continued examination in compliance with § 1.1 14 (for a utility or plant application only); or
`(c) Express abandonment ofthe application. Such express abandonment may be in favor ofa continuing application, but not a
`CPA under 37 CFR 1.53(d).
`
`Petition Fee
`
`@ Small Entity
`
`0 Micro Entity
`
`0 Regular Undiscounted
`
`Reason for withdrawal from issue
`
`Page 12 of 515
`
`Page 12 of 515
`
`

`
`0 One or more claims are unpatentable
`
`@ Consideration ofa request for continued examination (RCE)
`
`(List of Required Documents and Fees)
`
`0 Applicant hereby expressly abandons the instant application (any attorney/agent signing for this reason must
`have power of attorney pursuant to 37 CFR I.32(b)).
`
`RCE request,submission, and fee.
`
`I certify, in accordance with 37 CFR 1.4(d)(4) that:
`The RCE request ,submission, and fee have already been filed in the above—identified application on
`
`l:l
`
`Are attached.
`
`E T
`
`HIS PORTION MUST BE COMPLETED BY THE SIGNATORY OR SIGNATORIES
`
`I certify, in accordance with 37 CFR 1.4(d)(4) that I am:
`
`(9 An attorney or agent registered to practice before the Patent and Trademark Office who has been given power of attorney
`in this application.
`
`0 An attorney or agent registered to practice before the Patent and Trademark Office, acting in a representative capacity.
`
`0 A sole inventor
`
`O Ajoint inventor; I certify that I am authorized to sign this submission on behalfof all ofthe inventors
`
`O Ajoint inventor; all of whom are signing this e—petition
`
`O The assignee of record of the entire interest that has properly made itself of record pursuant to 37 CFR 3.71
`
`Slgnature
`
`Name
`
`
`
`/Jonathan C. Lovely, #60,821/
`
`Jonathan C. Lovely
`
`Registration Number
`
`60821
`
`Page 13 of 515
`
`Page 13 of 515
`
`

`
`Electronic Patent Application Fee Transmittal
`
`Title of Invention:
`
`Programmable Communicator
`
`;
`
`Utility under 35 USC111(a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`
`USD($)
`
`Basic Filing:
`
`Petition Fee-37CFR 1.1
`
`(Group
`
`RCE - 2nd and Subsequent Request
`
`2820
`
`1
`
`850
`
`850
`
`Miscellaneous-Filing:
`
`Patent-Appeals-and-Interference:
`
`Post-AlIowance-and-Post-Issuance:
`
`Page 14 of 515
`
`Page 14 of 515
`
`

`
`Extension-of-Time:
`
`Miscellaneous:
`
` S“:-S1-;(t$a)| in
`
`Total in USD (S)
`
`Page 15 of 515
`
`Page 15 of 515
`
`

`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Commissioner for Patents
`U nited States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`www.uspto.gov
`
`DECISIOTI Datei
`
`December 2, 2013
`
`In re Application of:
`
`Eveline Wesby—van Swaay
`
`Application N02
`
`Filed =
`
`16-Dec-2011
`
`Attorney Docket No:
`
`3731/1007
`
`DECISION ON PETITION
`
`UNDER CFR1.313(c)(2)
`
`This is an electronic decision on the petition under 37 CFR 1.313(c)(2), filed December 2, 2013, to withdraw the above—identified
`application from issue after payment of the issue fee.
`
`The petition is GRANTED.
`
`The above-identified application is withdrawn from issue for consideration ofa submission under 37 CFR 1.1 14 (request for
`continued examination). See 37 CFR1.313(c)(2).
`
`Petitioner is advised that the issue fee paid in this application cannot be refunded. If, however, this application is again
`allowed, petitioner may request that it be applied towards the issue fee required by the new Notice of Allowance.
`
`Telephone inquiries concerning this decision should be directed to the Patent Electronic Business Center (EBC) at 866-217-9197.
`
`This application file is being referred to Technology Center AU
`under 37 CFR 1.114.
`
`2582 for processing of the request for continuing examination
`
`Office of Petitions
`
`Page 16 of 515
`
`Page 16 of 515
`
`

`
`Electronic Acknowledgement Receipt
`
`m—
`
`Title of Invention:
`
`Programmable Communicator
`
`I—
`
`Payment information:
`
`yes—
`Submitted with Payment
`
`
`
`—Auth°“zedUser
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`Page 17 of 515
`
`Page 17 of 515
`
`

`
`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`Information:
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Quick Path Information Disclosure
`Statement
`
`3781_1007_QP|DS.pdf
`
`afda8ad7f50ac36ead2a60accb6d5504db2
`5493
`
`_
`_
`Information Disclosure Statement (IDS)
`Form (SE08)
`
`3781_1007_lDS.pdf
`
`50cebd99cffd6ec6f709ab30514adef2bab3
`4933
`
`612268
`
`A U.S. Patent Number Citation ora U.S. Publication Number Citation is required in the Information Disclosure Statement (IDS) form for
`autoloading of data into USPTO systems. You may remove the form to add the required data in order to correct the Informational Message if
`you are citing U.S. References. Ifyou chose not to include U.S. References, the image ofthe form will be processed and be made available
`within the Image File Wrapper (IFW) system. However, no data will be extracted from this form. Any additional data such as Foreign Patent
`Documents or Non Patent Literature will be manually reviewed and keyed into USPTO systems.
`
`Non Patent Literature
`
`3781_1007_Ref_1.pdf
`
`1603007
`
`a80cb35a3c08b423e201f09ae1d31b8c8cf5
`0044
`
`Information:
`
`_
`_
`_
`Request for Continued Examination
`(RCE)
`
`3781 1007 RCE. df
`-
`-
`'°
`
`797868
`
`36e6ea4bl 398e6a I 5e0l 634ab778e7c762l
`be97b
`
`8c8c40b08f8983d4094d96d7e835fe76843
`ccb15
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`b84l 24c2d9f7b53l I I 79e4e93cde8e754a7
`57fcc
`
`Page 18 of 515
`
`Page 18 of 515
`
`

`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/R0/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Page 19 of 515
`
`Page 19 of 515
`
`

`
`PTO!SBf08a (01-10)
`Doc code: IDS
`th
`df
`A
`h 07/302012. OMB 0651-0031
`.
`.
`.
`.
`.
`U_s_ Patent and Tragzggfk O‘:;::eU_§"EfiEPARTMENT OF COMMERCE
`Doc description: Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Application Number
`
`Filing Date
`
`13328095
`
`2011-12-16
`
`First Named Inventor
`Eveline Wesby—van Swaay
`Art Unit
`| 2682
`Examiner Name
`Nam V. Nguyen
`Attorney Docket Number
`| 3781/1007
`
`E).(‘?m*iner Cite
`
`Initial
`